Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$0.13 - $76.84 $19,765 - $11.7 Million
-152,044 Reduced 88.54%
19,687 $1.4 Million
Q2 2022

Aug 11, 2022

BUY
$72.62 - $79.98 $7.09 Million - $7.8 Million
97,581 Added 131.6%
171,731 $13.2 Million
Q1 2022

May 12, 2022

SELL
$61.48 - $73.72 $7.2 Million - $8.64 Million
-117,170 Reduced 61.24%
74,150 $5.42 Million
Q4 2021

Feb 09, 2022

SELL
$53.63 - $62.52 $2.02 Million - $2.35 Million
-37,587 Reduced 16.42%
191,320 $11.9 Million
Q3 2021

Nov 10, 2021

BUY
$59.17 - $69.31 $8.44 Million - $9.88 Million
142,613 Added 165.26%
228,907 $13.5 Million
Q2 2021

Aug 12, 2021

SELL
$61.91 - $67.42 $1.37 Million - $1.49 Million
-22,071 Reduced 20.37%
86,294 $5.77 Million
Q1 2021

May 13, 2021

BUY
$59.34 - $66.74 $1.92 Million - $2.16 Million
32,414 Added 42.68%
108,365 $6.84 Million
Q4 2020

Feb 12, 2021

BUY
$57.74 - $65.43 $1.44 Million - $1.63 Million
24,977 Added 49.0%
75,951 $4.71 Million
Q3 2020

Nov 12, 2020

BUY
$57.43 - $63.64 $1.71 Million - $1.89 Million
29,707 Added 139.69%
50,974 $3.07 Million
Q2 2020

Aug 12, 2020

SELL
$54.82 - $64.09 $1.42 Million - $1.66 Million
-25,976 Reduced 54.98%
21,267 $1.25 Million
Q1 2020

May 13, 2020

BUY
$46.4 - $67.43 $1.47 Million - $2.13 Million
31,612 Added 202.24%
47,243 $2.63 Million
Q4 2019

Feb 12, 2020

SELL
$49.21 - $64.19 $1.22 Million - $1.59 Million
-24,800 Reduced 61.34%
15,631 $1 Million
Q3 2019

Nov 12, 2019

SELL
$42.77 - $50.71 $5.32 Million - $6.3 Million
-124,312 Reduced 75.46%
40,431 $2.05 Million
Q2 2019

Aug 12, 2019

BUY
$44.62 - $49.34 $4.06 Million - $4.49 Million
91,088 Added 123.67%
164,743 $7.47 Million
Q1 2019

May 10, 2019

BUY
$45.12 - $53.8 $2.17 Million - $2.59 Million
48,055 Added 187.71%
73,655 $3.51 Million
Q4 2018

Feb 11, 2019

BUY
$48.76 - $63.23 $1.25 Million - $1.62 Million
25,600 New
25,600 $1.33 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $120B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Alpha Crest Capital Management LLC Portfolio

Follow Alpha Crest Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Crest Capital Management LLC with notifications on news.